Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy

Presented By: David Schaffer

Speaker Biography: David Schaffer is the Hubbard Howe Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience at the University of California, Berkeley, where he also serves as the Director of the Berkeley Stem Cell Center. He received a B.S. from Stanford University in 1993 and a Ph.D. from MIT in 1998.

Webinar: Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy

Webinar Abstract: To gain an understanding of how preclinical and clinical research in gene therapy is leading to strong advances and clinical approvals

To discuss how improvements in delivery technologies, such as engineered AAV delivery vectors, are still needed to fully unlock the potential of gene therapy and genome editing

Earn PACE Credits:

LabRoots on Social:
SnapChat: labroots_inc

[shadisaiid]

great presentation, very interesting, will be mentioning alot of this information on my presentation tomorrow, thank you smart man.

[edthoreum]

4:39 gene THERAPY 🔨
6:00 AAv virus vectors to the mission
12:00 better virus vector?
16:45 👁️

[George-rqyp]

He recklessly prepared his slides: missing text, overlapping texts, etc. But great presentation.

[janosantal]

The audio part of the presentation is several times problematic. For non native English speaking colleagues, as me, it is problematic several times to understand because of the missing syllables, words.

[immigrantworld]

I am so weak brothers, I cant cook well, get jobs, distinguish green or yellow traffic light, match the clothes, and etc. Protan color blindness, is very big disabillity for me.